FDG-PET in lung cancer: Differential diagnosis, staging, search for recurrence and impact on decision making;La tomographie par émission de positons (TEP) [18F]-FDG dans les cancers bronchopulmonaires et son impact sur la décision médicale: Lors du diagnostic, de la stadification ou de la recherche de récidive

Revue de Pneumologie Clinique

Volumn 57, Issue 6, 2001, Pages 393-403

  Grahek, D ^a   Montravers, F ^a   Mayaud, C ^a   Regnard, J F ^b   Kerrou, K ^a   Younsi, N ^a   Talbot, J N ^a  

^a HÔPITAL TENON   (France)

^b HÔTEL DIEU   (France)

Author keywords

18F FDG; Cancer; CDET; Clinical impact; Lung; Medical imaging; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FRANCE; HUMAN; IMAGE ANALYSIS; LUNG CANCER; MEDICAL DECISION MAKING; META ANALYSIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035704337     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Prevalence of adverse reaction to positron emitting radiopharmaceuticals in nuclear medicine
2. A tabulated summary of the FDG PET literature
3. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis
4. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung
5. Likelihood of malignancy in a solitary pulmonary nodule: Comparison of Bayesian analysis and results in FDG-PET scan
6. Comparative efficacy of FDG-PET in evaluation of small (<, 3cm) and large (>, 3cm) pulmonary and lymph node lesions
7. Contribution of the FDG scintigraphy on an dual head coincidence gammacamera (CDET) to the characterisation of pulmonary lesions and staging of lung cancer
8. Evaluation of primary pulmonary carcinoid tumors using FDG PET
9. Localized form of bronchioloalveolar carcinoma: FDG PET findings
10. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiological Diagnostic Oncology Group
11. Lymph node staging in non-small-cell lung cancer with FDG-PET Scan: A prospective study on 690 lymph node stations from 68 patients
12. Non-small cell lung cancer nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling
13. Preoperative staging of non-small cell lung cancer with positron-emission tomography
14. Evaluation of adrenal masses in lung cancer using 18FDG PET
15. Skeletal metastases in lung cancer: Accuracy of 18FDG-PET in correlation with bone scintigraphy
16. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<, 1cm), intermediate (1 to 3 cm), and large (>, 3cm) lymph node lesions
17. Distribution of bone metastases in lung cancer
18. Combined PET/CT imaging in oncology: Impact on patient management
19. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps
20. CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
21. Un an d'activité du centre TEP AP-HP; impact de la TEP au [18F]-FDG sur la décision médicale en cancérologie
22. Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study
23. Prospective survey of referring physicians to determine the impact of whole body FDG-PET on management of cancer patients